ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 148 filers reported holding ANAVEX LIFE SCIENCES CORP in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,988 | +1.5% | 16,792 | +25.9% | 0.00% | – |
| Q2 2023 | $108,397 | +1.7% | 13,333 | +7.2% | 0.00% | – |
| Q1 2023 | $106,619 | -54.6% | 12,441 | -51.0% | 0.00% | -100.0% |
| Q4 2022 | $235,000 | -11.7% | 25,378 | -1.5% | 0.00% | 0.0% |
| Q3 2022 | $266,000 | +9.5% | 25,771 | +6.0% | 0.00% | 0.0% |
| Q2 2022 | $243,000 | -30.6% | 24,302 | -14.5% | 0.00% | 0.0% |
| Q1 2022 | $350,000 | -44.7% | 28,419 | -22.1% | 0.00% | 0.0% |
| Q4 2021 | $633,000 | +15.1% | 36,480 | +19.1% | 0.00% | 0.0% |
| Q3 2021 | $550,000 | -17.5% | 30,626 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $667,000 | +56.9% | 29,195 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $425,000 | +98.6% | 28,419 | -28.3% | 0.00% | – |
| Q4 2020 | $214,000 | +23.7% | 39,632 | +4.5% | 0.00% | – |
| Q3 2020 | $173,000 | -2.3% | 37,938 | +5.3% | 0.00% | – |
| Q2 2020 | $177,000 | +172.3% | 36,015 | +75.2% | 0.00% | – |
| Q1 2020 | $65,000 | – | 20,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 942,500 | $9,727,000 | 3.29% |
| Pier Capital, LLC | 384,811 | $3,971,000 | 0.68% |
| AllSquare Wealth Management LLC | 65,956 | $681,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $1,032,000 | 0.35% |
| Royal Capital Wealth Management, LLC | 18,500 | $191,000 | 0.22% |
| Bridgefront Capital, LLC | 10,214 | $105,000 | 0.11% |
| Hikari Power Ltd | 85,585 | $883,000 | 0.10% |
| Orion Capital Management LLC | 9,500 | $98,000 | 0.08% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 86,158 | $889,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 66,459 | $686,000 | 0.04% |